JP2019535677A5 - - Google Patents

Download PDF

Info

Publication number
JP2019535677A5
JP2019535677A5 JP2019521662A JP2019521662A JP2019535677A5 JP 2019535677 A5 JP2019535677 A5 JP 2019535677A5 JP 2019521662 A JP2019521662 A JP 2019521662A JP 2019521662 A JP2019521662 A JP 2019521662A JP 2019535677 A5 JP2019535677 A5 JP 2019535677A5
Authority
JP
Japan
Prior art keywords
msc
prostacyclin
exposed
pharmaceutical composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019521662A
Other languages
English (en)
Japanese (ja)
Other versions
JP7179723B2 (ja
JP2019535677A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/057863 external-priority patent/WO2018080990A1/en
Publication of JP2019535677A publication Critical patent/JP2019535677A/ja
Publication of JP2019535677A5 publication Critical patent/JP2019535677A5/ja
Application granted granted Critical
Publication of JP7179723B2 publication Critical patent/JP7179723B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019521662A 2016-10-24 2017-10-23 トレプロスチニルによるmscの免疫調節特性の増強 Active JP7179723B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662411950P 2016-10-24 2016-10-24
US62/411,950 2016-10-24
PCT/US2017/057863 WO2018080990A1 (en) 2016-10-24 2017-10-23 Enhancement of msc immunomodulatory properties by treprostinil

Publications (3)

Publication Number Publication Date
JP2019535677A JP2019535677A (ja) 2019-12-12
JP2019535677A5 true JP2019535677A5 (cg-RX-API-DMAC7.html) 2020-11-26
JP7179723B2 JP7179723B2 (ja) 2022-11-29

Family

ID=60570174

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019521662A Active JP7179723B2 (ja) 2016-10-24 2017-10-23 トレプロスチニルによるmscの免疫調節特性の増強

Country Status (10)

Country Link
US (2) US11571444B2 (cg-RX-API-DMAC7.html)
EP (1) EP3534917B1 (cg-RX-API-DMAC7.html)
JP (1) JP7179723B2 (cg-RX-API-DMAC7.html)
KR (1) KR102606101B1 (cg-RX-API-DMAC7.html)
CN (1) CN110177559A (cg-RX-API-DMAC7.html)
AU (1) AU2017350732B2 (cg-RX-API-DMAC7.html)
CA (1) CA3041514A1 (cg-RX-API-DMAC7.html)
ES (1) ES2927406T3 (cg-RX-API-DMAC7.html)
IL (1) IL266175B2 (cg-RX-API-DMAC7.html)
WO (1) WO2018080990A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6746313B2 (ja) 2012-08-01 2020-08-26 ユナイテッド セラピューティクス コーポレイション プロスタサイクリン処理された内皮前駆細胞による肺動脈性高血圧症の処置
KR102466885B1 (ko) 2013-01-09 2022-11-11 유나이티드 세러퓨틱스 코오포레이션 프로스타시클린 및 중간엽 줄기 세포를 사용한 혈관병증의 치료
US12303534B2 (en) 2018-06-05 2025-05-20 Medipost Co., Ltd Pharmaceutical composition comprising mesenchymal stem cells as effective ingredient for prevention or treatment of inflammatory disease
US10883084B2 (en) 2018-10-05 2021-01-05 Xenotherapeutics, Inc. Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
MX2021003866A (es) 2018-10-05 2021-09-08 Xenotherapeutics Inc Productos y metodos de xenotransplante.
WO2020081859A1 (en) * 2018-10-18 2020-04-23 Nantbio, Inc. Mesenchymal stem cell derived exosomes and methods
CN113274411A (zh) * 2021-04-21 2021-08-20 西安市第一医院 经基因修饰的骨髓间充质干细胞来源的微囊泡在制备治疗肾损伤药物中的应用
CN118576532B (zh) * 2024-08-05 2024-11-26 北京青藤谷禧干细胞科技研究院有限公司 一种含干细胞外泌体的面部美容组合物及其制备方法和应用

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089815A (en) 1951-10-11 1963-05-14 Lieb Hans Injectable pharmaceutical preparation, and a method of making same
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4353888A (en) 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4965204A (en) 1984-02-06 1990-10-23 The Johns Hopkins University Human stem cells and monoclonal antibodies
US4714680B1 (en) 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US5130144B1 (en) 1984-02-06 1995-08-15 Univ Johns Hopkins Human stem cells and monoclonal antibodies
US5026365A (en) 1987-04-29 1991-06-25 The University Of Massachusetts Method and apparatus for therapeutically treating immunological disorders and disease states
US4983393A (en) 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
ATE81724T1 (de) 1987-11-09 1992-11-15 Becton Dickinson Co Verfahren zur analyse haematopoietischer zellen in einer probe.
US5283187A (en) 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US5158881A (en) 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US5071741A (en) 1988-04-18 1991-12-10 Cryolife, Inc. Cryoprotective agent and its use in cryopreservation of cellular matter
DE3829766A1 (de) 1988-09-01 1990-03-22 Akzo Gmbh Verfahren zur herstellung von membranen
DE3829752A1 (de) 1988-09-01 1990-03-22 Akzo Gmbh Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration
US5084350A (en) 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5283058A (en) 1990-08-30 1994-02-01 The General Hospital Corporation Methods for inhibiting rejection of transplanted tissue
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
SG47470A1 (en) 1991-04-25 1998-04-17 Univ Brown Res Found Implantable biocompatible immunoisolatory vehicle for delivery of a selected therapeutic products
IL104470A0 (en) 1992-01-21 1993-05-13 Cryopharm Corp Process for freezing cells and cell like materials and compositions prepared thereby
US5834256A (en) 1993-06-11 1998-11-10 Cell Genesys, Inc. Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
ES2178654T3 (es) 1993-08-12 2003-01-01 Neurotech Sa Capsulas biocompatibles inmonoaisladoras que contienen celulas geneticamente alteradas para el suministro de moleculas biologicamente activas.
US5518878A (en) 1993-09-15 1996-05-21 Organogenesis Inc. Cryopreservation of cultured skin or cornea equivalents with agitation
US5693531A (en) 1993-11-24 1997-12-02 The United States Of America As Represented By The Department Of Health And Human Services Vector systems for the generation of adeno-associated virus particles
EP0748215B1 (en) 1994-02-17 2003-05-28 New York Blood Center, Inc. Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
US7252989B1 (en) 1994-04-04 2007-08-07 Board Of Regents, The University Of Texas System Adenovirus supervector system
US5580714A (en) 1995-03-08 1996-12-03 Celox Laboratories, Inc. Cryopreservation solution
US5629145A (en) 1995-03-24 1997-05-13 Organ, Inc. Cryopreservation of cell suspensions
US5643192A (en) 1995-04-06 1997-07-01 Hamilton Civic Hospitals Research Development, Inc. Autologous fibrin glue and methods for its preparation and use
AU1333797A (en) 1995-12-15 1997-07-03 Systemix, Inc. Method for obtaining retroviral vector supernatant having high transduction efficiency
US5910434A (en) 1995-12-15 1999-06-08 Systemix, Inc. Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant
WO1998014058A1 (en) 1996-10-03 1998-04-09 The Regents Of The University Of California Cryopreservation of human adult and fetal pancreatic cells and human platelets
AU729420B2 (en) 1996-11-01 2001-02-01 Eurogene Limited Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
WO1999003973A1 (en) 1997-07-14 1999-01-28 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US9585916B2 (en) 1999-03-26 2017-03-07 Northern Therapeutics Inc. Cell based therapy for the pulmonary system
US20030118567A1 (en) 1999-03-26 2003-06-26 Stewart Duncan John Cell-based therapy for the pulmonary system
US6197294B1 (en) 1998-10-26 2001-03-06 Neurotech S.A. Cell surface molecule-induced macrophage activation
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
US9320829B2 (en) 2000-03-15 2016-04-26 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
AU7362301A (en) 2000-06-22 2002-01-02 Sam L Austin Bioadhesive compositions and methods of preparation and use
JP2006511312A (ja) 2002-11-30 2006-04-06 カーディアック・ペースメーカーズ・インコーポレーテッド 生体組織の細胞治療と電気治療の方法と装置
CN1917866B (zh) 2003-12-16 2010-12-15 联合治疗公司 曲前列环素或它的衍生物,或其药学上可接受的盐在制备治疗和预防缺血性损害的药物中的用途
TR201900968T4 (tr) 2004-09-24 2019-02-21 Mesoblast Inc Multipotansiyel genleşmiş mezenkimal prekürsör hücre soyu (memp) ve bunların kullanımı.
CA2619593C (en) 2005-08-19 2018-12-11 Duke University Stem cell derived factors for treating pathologic conditions
US20070065414A1 (en) 2005-09-16 2007-03-22 Boston Scientific Scimed, Inc. Enhanced delivery of cells
US8652201B2 (en) 2006-04-26 2014-02-18 The Cleveland Clinic Foundation Apparatus and method for treating cardiovascular diseases
US20090274665A1 (en) 2006-04-27 2009-11-05 Cell Therapy Technologies, Inc. Stem Cells For Treating Lung Diseases
WO2008077094A2 (en) 2006-12-19 2008-06-26 Children's Medical Center Corporation Methods for promoting neovascularization
CN103356710A (zh) 2007-02-12 2013-10-23 人类起源公司 利用胎盘干细胞治疗炎性疾病
JP2011015609A (ja) 2007-10-30 2011-01-27 Asahikawa Medical College 内皮前駆細胞(epc)の増殖・分化誘導方法
PT2254586E (pt) 2008-02-22 2015-05-18 Agency Science Tech & Res Partículas de células estaminais mesenquimais
KR101920891B1 (ko) 2010-08-27 2018-11-21 조슈아 엠 헤어 심장 치료를 위한 골수 유래 cd271 전구 세포
CA2850484C (en) 2011-09-30 2021-01-26 Bluebird Bio, Inc. Compounds for improved viral transduction
JP6746313B2 (ja) * 2012-08-01 2020-08-26 ユナイテッド セラピューティクス コーポレイション プロスタサイクリン処理された内皮前駆細胞による肺動脈性高血圧症の処置
CN104684561A (zh) * 2012-08-01 2015-06-03 联合治疗公司 利用间充质干细胞的肺动脉高血压的治疗
KR102466885B1 (ko) * 2013-01-09 2022-11-11 유나이티드 세러퓨틱스 코오포레이션 프로스타시클린 및 중간엽 줄기 세포를 사용한 혈관병증의 치료

Similar Documents

Publication Publication Date Title
JP2022107023A5 (cg-RX-API-DMAC7.html)
JPWO2019107530A1 (ja) 炎症性腸疾患の治療薬
JP2023520233A5 (cg-RX-API-DMAC7.html)
JP2017505761A5 (cg-RX-API-DMAC7.html)
JP2019206562A5 (cg-RX-API-DMAC7.html)
KR20120100962A (ko) 신장 손상을 치료하는데 사용하기 위한 조혈 줄기 세포
RU2015154737A (ru) Пролонгированное высвобождение нейрегулина для лечения сердечной недостаточности
JP2021515042A (ja) ムチンに作用するプロテアーゼを含む製剤
JP2024516172A5 (cg-RX-API-DMAC7.html)
JP2019535677A (ja) トレプロスチニルによるmscの免疫調節特性の増強
EP3302523A1 (fr) Composition pour le traitement des lesions tissulaires
He et al. Exosome-equipped TNF antisense oligodeoxynucleotide or 2-deoxy-D-glucose ameliorated nonalcoholic steatohepatitis by modulating superoxide dismutase 1 in mice
Chen et al. Current state of heart failure treatment: are mesenchymal stem cells and their exosomes a future therapy?
Song et al. Therapeutic factors and biomaterial-based delivery tools for degenerative intervertebral disc repair
JP5841903B2 (ja) 肝障害の治療または肝機能の向上のための薬剤
CN112972389A (zh) 甘草酸纳米颗粒的合成及其在新型冠状病毒肺炎中的联合治疗应用
CN107296806A (zh) 丹酚酸a作为脂蛋白相关磷脂酶a2抑制剂的新用途
CA2593161A1 (en) Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries
JP2017507123A (ja) 歯原性幹細胞および遺伝的に改変された歯原性幹細胞の使用
CN118873667A (zh) Lat1抑制剂在制备治疗动脉粥样硬化的药物中的应用
US10328122B2 (en) Method of treating fulminant hepatic failure using DLL4 cytokine
CN119499243B (zh) 一种生物碱用于制备t细胞免疫抑制剂的应用
WO2018215571A1 (en) Method for genetically modifying a vascularised tissue
Hillestad et al. Quinidine before direct current countershock. A controlled study
JP2012056913A (ja) 脂肪組織由来間質細胞群を含む肝炎治療剤